Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jun 26, 2025

ETF Performance Analysis: June 2025 Surge in $SPY, $QQQ, $IWM, and $DIA Due to AI-Driven Trading and Geopolitical Changes

The week of June 17-24, 2025, marked a pivotal period for major U.S. exchange-traded funds (ETFs), with the SPDR S&P 500 ETF Trust (SPY), Invesco QQQ Trust (QQQ), iShares Russell 2000 ETF (IWM), and SPDR Dow Jones Industrial Average ETF Trust (DIA) exhibiting notable movements. This article delves into their performance, the factors driving these changes, and the outlook for the current and upcoming weeks, while integrating insights from Tickeron.com and highlighting the role of AI-driven trading strategies.

Last Week’s Performance: June 17-24, 2025

The week ending June 24, 2025, saw mixed but predominantly bullish performance across major ETFs, driven by geopolitical developments and market optimism. According to Tickeron.com, the SPDR S&P 500 ETF Trust (SPY) gained 1.11% on June 24, closing at 6,092.18, just 0.9% shy of its all-time high. The Invesco QQQ Trust (QQQ) outperformed with a 1.43% increase, propelled by tech sector strength, particularly Nvidia’s 4% surge. The SPDR Dow Jones Industrial Average ETF Trust (DIA) rose 1.19%, closing at 42,982.43 after a 507.24-point jump. In contrast, the iShares Russell 2000 ETF (IWM) showed signs of weakness, with a year-to-date decline of approximately 5.3% as of June 20, though it challenged its 200-day moving average with nascent bullish signals.

Key Drivers of Market Movement

Several factors influenced these performances. A reported ceasefire between Israel and Iran on June 23, 2025, lifted investor sentiment, contributing to a 6% drop in oil prices, which bolstered equity markets. Additionally, optimism over U.S.-China trade negotiations and strong corporate earnings mitigated earlier volatility from tariff concerns and Federal Reserve rate uncertainties. The technology sector, led by the “Magnificent Seven” stocks (Nvidia, Apple, Alphabet, Microsoft, Amazon, Meta, Tesla), drove the Nasdaq’s 1.53% gain, directly benefiting QQQ. However, IWM’s underperformance reflected caution in the small-cap sector, with its 10-day RSI moving out of overbought territory on June 11, signaling potential downward pressure.

Popular Market News on June 25, 2025

On June 25, 2025, market news highlighted a mixed yet optimistic outlook. CNBC reported the S&P 500 hovering near its record high of 6,092.16, with the Nasdaq Composite up 0.31% at 19,973.55, driven by tech gains. The Dow, however, slipped 106.59 points (0.25%), reflecting caution over Federal Reserve Chair Jerome Powell’s comments on potential inflation increases. A CNN Business report noted the S&P 500’s 20% recovery since April lows, shrugging off tariff concerns and Middle East tensions. Additionally, Bloomberg highlighted declining Treasury yields and a weaker dollar amid speculation of earlier-than-expected Fed rate cuts, boosting equity sentiment. These developments underscored the resilience of SPY and QQQ, while DIA and IWM faced more tempered gains.

Comparison with a Highly Correlated Stock: NVDA

The performance of SPY is closely tied to high-beta stocks like Nvidia (NVDA), which has a beta of 1.7 compared to SPY’s 1.0. On June 23, 2025, NVDA declined 1.1% due to U.S.-China trade tensions, while SPY’s diversified exposure limited its drop to 0.2%. NVDA’s $3.46 trillion market cap and AI-driven growth significantly influence SPY’s upside, but its higher volatility introduces risk. This correlation highlights SPY’s stability for risk-averse investors, while NVDA offers higher reward potential with increased risk.

Leveraging Inverse ETFs for Strategic Trading

Pairing SPY with an inverse ETF like the ProShares Short S&P 500 (SH) offers traders a strategic hedge. SH is designed to deliver the daily inverse performance of the S&P 500, providing perfect anti-correlation to SPY. By holding long positions in SPY and selectively using SH, traders can capitalize on bullish trends while mitigating losses during market corrections. For instance, on June 12, 2025, when SPY futures dipped 0.56%, SH likely saw a corresponding uptick, enabling traders to offset losses. This approach, supported by Tickeron’s AI-driven insights, enhances risk management in volatile markets.

Tickeron’s AI-Powered Trading Tools

Tickeron, under CEO Sergey Savastiouk, is revolutionizing trading through its Financial Learning Models (FLMs). These models combine advanced technical analysis with AI to identify market patterns with precision. Tickeron’s offerings include user-friendly trading bots for beginners, high-liquidity stock robots for efficient execution, and real-time AI insights for transparency. The Tickeron AI Trading Bots and Double Agents provide dual-perspective signals, identifying both bullish and bearish trends. For example, Tickeron’s Double Agent Bot achieved a +9.77% quarterly gain while the S&P 500 dropped 9.28%, showcasing AI’s edge in turbulent markets. These tools empower traders to optimize strategies for ETFs like SPY, QQQ, IWM, and DIA.

SH

AI Robots (Virtual Accounts)

AI Robot’s NameP/LVTI / SH Trading Results AI Trading Double Agent, 60 min13.19%

NVDA

AI Robots (Signals Only)

AI Robot’s NameP/LNVDA / SOXS – Trading Results AI Trading Double Agent, 15min297.56%NVDA / NVDS Trading Results AI Trading Double Agent, 60 min112.02%Swing Trader, Popular Stocks: Price Action Trading Strategy – Pro Version (TA&FA), 60 min17.01%

AI Robots (Virtual Accounts)

AI Robot’s NameP/LNVDA / NVDS Trading Results AI Trading Double Agent, 60 min112.15%Swing Trader: Search for Dips in Top 10 Giants (TA), 60 min40.95%Swing Trader: Tracking Dip Trends in Industrial Stocks (TA) – Trading Results, 60 min15.84%

QQQ

AI Robots (Virtual Accounts)

AI Robot’s NameP/LQQQ / QID Trading Results AI Trading Double Agent, 60 min52.29%

Current Week Outlook: June 24-30, 2025

For the current week, market sentiment remains cautiously optimistic. SPY’s Momentum Indicator turned positive on June 24, suggesting a potential 12-18.5% upside, with Elliott Wave analysis targeting $627–$647. QQQ is poised to test 540, potentially reaching 564 in four weeks if it holds, driven by tech momentum. DIA faces resistance after its 1.19% gain, with futures indicating flat movement. IWM may see continued pressure, as its MACD turned negative on June 13, signaling potential declines. Traders should monitor Federal Reserve signals and geopolitical developments, particularly U.S.-China trade talks, for volatility triggers.

Next Week Forecast: July 1-7, 2025

Looking ahead to July 1-7, 2025, analysts anticipate continued strength in SPY and QQQ, with forecasts suggesting a 5-6% uptick for the S&P 500, potentially reaching 6,500. DIA may lag slightly due to its exposure to industrial and financial sectors, which are sensitive to tariff uncertainties. IWM’s small-cap focus could face challenges if inflation concerns resurface, though bullish momentum may persist if it holds above its 200-day moving average. Posts on X indicate cautious sentiment, with some traders noting signs of exhaustion in SPY and QQQ, suggesting profit-taking could temper gains. Tickeron’s AI tools recommend buying dips in SPY and QQQ while hedging with inverse ETFs like SH for risk management.

Conclusion

The week of June 17-24, 2025, showcased robust performance for SPY, QQQ, and DIA, driven by geopolitical optimism and tech sector strength, while IWM lagged due to small-cap caution. Tickeron’s AI-driven insights and inverse ETF strategies offer traders tools to navigate volatility. As markets approach record highs, leveraging AI tools and staying informed via platforms like Tickeron.com will be crucial for capitalizing on opportunities in the weeks ahead.

 Disclaimers and Limitations

Related Ticker: SPY, QQQ, IWM, DIA

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


SPY in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 10, 2026

SPY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 38 cases where SPY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on SPY as a result. In 63 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for SPY just turned positive on September 22, 2026. Looking at past instances where SPY's MACD turned positive, the stock continued to rise in 43 of 53 cases over the following month. The odds of a continued upward trend are 81%.

SPY moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPY advanced for three days, in 303 of 362 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for SPY entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), Broadcom Inc. (NASDAQ:AVGO), Tesla (NASDAQ:TSLA), Micron Technology (NASDAQ:MU).

Industry description

The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index. The trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the “Portfolio”), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index.

Market Cap

The average market capitalization across the State Street SPDR S&P 500 ETF (SPY) ETF is 161B. The market cap for tickers in the group ranges from 6B to 5.49T. NVDA holds the highest valuation in this group at 5.49T. The lowest valued company is TTD at 6B.

High and low price notable news

The average weekly price growth across all stocks in the State Street SPDR S&P 500 ETF (SPY) ETF was 23%. For the same ETF, the average monthly price growth was 46%, and the average quarterly price growth was 293%. MRNA experienced the highest price growth at 25%, while GEN experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the State Street SPDR S&P 500 ETF (SPY) ETF was 1%. For the same stocks of the ETF, the average monthly volume growth was 26% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 51
Price Growth Rating: 50
SMR Rating: 50
Profit Risk Rating: 61
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
SPY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeBlend

Category
Large Blend
Address
PDR Services, 86 Trinity PlaceNew York
Phone
N/A
Web
www.spdrs.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.